Clinical Trials » Stargardt Disease
Saffron Supplementation for Stargardt Disease: Italy
|
RECRUITING Description: The Catholic University of the Sacred Heart in Italy is conducting a 30-person clinical trial of saffron for the treatment of Stargardt disease. Saffron contains high concentrations of crocin and crocetin, compounds with anti-oxidative properties. Saffron supplementation has inhibited retinal degeneration in lab studies. Trial Status: Recruiting participants. Partial List of Participation Criteria:
Benedetto Falsini, M.D. This e-mail address is being protected from spambots. You need JavaScript enabled to view it Phone: 0039063015 ext. 4929 Policlinico A. Gemelli Rome, Italy Additional Information: Saffron supplementation clinical trial for Stargardt disease listing on ClinicalTrials.gov |
